1. Home
  2. ORKA vs VVV Comparison

ORKA vs VVV Comparison

Compare ORKA & VVV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Oruka Therapeutics Inc.

ORKA

Oruka Therapeutics Inc.

HOLD

Current Price

$84.33

Market Cap

4.4B

Sector

Health Care

ML Signal

HOLD

Logo Valvoline Inc.

VVV

Valvoline Inc.

HOLD

Current Price

$38.34

Market Cap

4.2B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
ORKA
VVV
Founded
2004
1866
Country
United States
United States
Employees
68
N/A
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Major Chemicals
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
4.4B
4.2B
IPO Year
N/A
2016

Fundamental Metrics

Financial Performance
Metric
ORKA
VVV
Price
$84.33
$38.34
Analyst Decision
Strong Buy
Buy
Analyst Count
12
15
Target Price
$92.50
$40.00
AVG Volume (30 Days)
1.2M
2.1M
Earning Date
05-13-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
1.86
EPS
N/A
0.09
Revenue
N/A
$2,285,000,000.00
Revenue This Year
N/A
$20.80
Revenue Next Year
N/A
$10.50
P/E Ratio
N/A
$417.11
Revenue Growth
N/A
9.64
52 Week Low
$10.97
$28.50
52 Week High
$91.00
$41.33

Technical Indicators

Market Signals
Indicator
ORKA
VVV
Relative Strength Index (RSI) 73.62 65.10
Support Level $27.81 $31.67
Resistance Level $91.00 $39.21
Average True Range (ATR) 4.67 1.08
MACD 2.31 0.16
Stochastic Oscillator 87.12 87.61

Price Performance

Historical Comparison
ORKA
VVV

About ORKA Oruka Therapeutics Inc.

Oruka Therapeutics Inc a clinical-stage biopharmaceutical company focused on developing novel monoclonal antibody therapeutics for psoriasis (PsO) and other inflammatory and immunology (I&I) indications. Its programs are to treat and potentially modify disease by targeting mechanisms with efficacy and safety involved in disease pathology and the activity of pathogenic tissue-resident memory T cells (TRMs). Its program, ORKA-001, is designed to target the p19 subunit of interleukin-23 (IL-23p19) for the treatment of PsO. Its co-lead program, ORKA-002, is designed to target interleukin-17A and interleukin-17F (IL-17A/F) for the treatment of PsO, hidradenitis suppurativa (HS), psoriatic arthritis (PsA), and other conditions.

About VVV Valvoline Inc.

Valvoline Inc provides automotive preventive maintenance through retail stores across the U.S. and Canada, offering approximately 15-minute stay-in-your-car oil changes, battery, bulb, and wiper replacements, tire rotations, and other manufacturer-recommended maintenance. Its full-service oil changes include Valvoline oil, a new oil filter, chassis lubrication, and an 18-point maintenance check. The Company provides differential fluid, fuel system cleaning, headlight and taillight replacement, radiator service, transmission service, air conditioning, and air filter replacement. It operates and franchises approximately 2,200 Valvoline Instant Oil Change and Valvoline Great Canadian Oil Change retail locations. The majority of revenue is generated from the United States of America.

Share on Social Networks: